FDA Enables Generic Insulins with Lower Prices
Insulin Nation
MARCH 26, 2020
A long-standing issue with insulin is the lack of a “generic.” These critical therapies often carry a heavy price tag; the cost of insulin has risen over the past decade. While COVID-19 has distracted our attention from affordable insulin to focus on social distancing and hoarding toilet paper, the U.S. Why no Generic Insulins?
Let's personalize your content